Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Degenerative Diseases, Central Nervous System

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayala, GX1
Tapia, R1

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Degenerative Diseases, Central Nervous System

ArticleYear
HSP70 expression protects against hippocampal neurodegeneration induced by endogenous glutamate in vivo.
    Neuropharmacology, 2008, Volume: 55, Issue:8

    Topics: 4-Aminopyridine; Animals; Cell Count; Disease Models, Animal; Dizocilpine Maleate; Electroencephalog

2008